Patent 12123880

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Active provider: Google · gemini-2.5-flash

PTAB activity (1)

AIA trial proceedings — IPR, PGR, CBM — filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced directly from the PTAB Trial API.

  • IPR2026-00168IPRfiled Dec 2, 2025vs. Sarepta Therapeutics, Inc. et al.Institution Denied

Cached for 24 hours. Status strings are sourced verbatim from the PTAB API; the colored badge is our heuristic classification.

Cases on file (1)

Group view →

Specific litigation cases in our database that name US patent 12123880. The free-form analysis below may also discuss cases beyond this list.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

✓ Generated

As of April 26, 2026, known litigation involving US patent 12123880 includes one Inter Partes Review (IPR) proceeding before the Patent Trial and Appeal Board (PTAB).

Case Details:

  • Case Number: IPR2026-00168 [cite: US12123880B2]
  • Jurisdiction: Patent Trial and Appeal Board (PTAB) [cite: US12123880B2]
  • Plaintiff(s)/Petitioner(s): Unified Patents [cite: US12123880B2]
  • Defendant(s)/Patent Owner(s): Genzyme Corp [cite: US12123880B2]
  • Filing Date: 2026 (implied by the case number IPR2026-00168). A more specific filing date is not available in the provided information.
  • Outcome or Current Status: Pending [cite: US12123880B2]

No other litigation involving US patent 12123880 was found in the search results from CAFC or PACER.

Generated 5/27/2026, 12:47:15 PM